Company / Cash per Share
Bone Biologics Corp Cash per Share History
FY2017-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.00
FY2019
5-year range
$0.00 / $0.16
FY2017-FY2019
Trend
-99.4%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.02 to $0.00 over the past 2 years.
Based on SEC 10-K filings.
0.00 in FY2019.
Declined from $0.02 to $0.00 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, cash per share decreased 99.4% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | - | - |
| FY2019 | $0.00 | -99.4% |
| FY2018 | $0.16 | +898.2% |
| FY2017 | $0.02 | - |
As of FY2019 · SEC 10-K · Updated Jun 28, 2026